Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The FINAL Study: Naltrexone in Fibromyalgia
NCT04270877Phase 2Completed
- Sponsor
- University Hospital Odense
- Start
- Jan 2021
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of naltrexone in fibromyalgia (FM), sponsored by University Hospital Odense. Started Jan 2021; status: completed.
02
Drugs
naltrexone
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT04270877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04270877.